Medicare Enrolled

Dr. Teresa Deangelis, M.D.

Neurology · New York, NY
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
5 E 98TH ST, New York, NY 10029
2122416854
In practice since 2006 (20 years)
NPI: 1164463808 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Deangelis from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Deangelis? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Deangelis

Dr. Teresa Deangelis is a neurology specialist in New York, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Deangelis performed 1,379 Medicare services across 1,038 unique beneficiaries.

Between the years covered by Open Payments, Dr. Deangelis received a total of $107,968 from 66 pharmaceutical and/or device companies across 900 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Deangelis is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 23% volume in NY $107,968 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,379
Medicare services
Top 23% in NY for neurology
1,038
Unique beneficiaries
$97
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~69 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
668 $107 $149
Advance care planning consultation, first 30 min
A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion.
359 $72 $96
New patient office visit, complex (60-74 min) 79 $192 $254
Psychological test administration, first 30 minutes
A technician administers psychological or neuropsychological testing for the first 30 minutes.
55 $32 $43
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
54 $72 $90
Psychological test administration, each additional 30 minutes
A technician administers psychological or neuropsychological testing. This code covers each additional 30-minute increment of administration time.
50 $34 $42
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
37 $137 $211
Neuropsychological test evaluation, first hour
A professional assessment of cognitive and behavioral functioning using standardized tests. This service covers the initial hour of the evaluation process.
31 $116 $144
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
29 $135 $193
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
17 $119 $149
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$107,968
Total received (2018-2024)
Avg $15,424/year across 7 years
Top 7% in NY for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
66
Companies
900
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$97,299 (90.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,669 (9.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$7,054
2023
$16,892
2022
$23,215
2021
$7,854
2020
$19,500
2019
$19,306
2018
$14,148

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Biogen, Inc.
$4,100
Novartis Pharmaceuticals Corporation
$443
ABBVIE INC.
$439
Amgen Inc.
$307
Takeda Pharmaceuticals U.S.A., Inc.
$205
PFIZER INC.
$181
EMD Serono, Inc.
$149
Celgene Corporation
$146
Alexion Pharmaceuticals, Inc.
$135
Eisai Inc.
$134
Lundbeck LLC
$133
TG Therapeutics, Inc.
$96
ACADIA Pharmaceuticals Inc
$86
Grifols USA, LLC
$73
Genentech USA, Inc.
$63
Lilly USA, LLC
$62
SK Life Science, Inc.
$43
Otsuka America Pharmaceutical, Inc.
$42
Amylyx Pharmaceuticals, Inc.
$41
Neuronetics, Inc.
$40
ARGENX US, INC.
$33
CSL Behring
$28
UCB, Inc.
$24
MDD US Operations, LLC
$18
Vanda Pharmaceuticals Inc.
$16
Acorda Therapeutics, Inc
$15
Top 3 companies account for 70.6% of 2024 payments
All-time payments by company (2018-2024) ›
Biogen, Inc.
$74,129
Alexion Pharmaceuticals, Inc.
$13,574
Horizon Therapeutics plc
$9,888
Novartis Pharmaceuticals Corporation
$1,526
EMD Serono, Inc.
$951
AbbVie Inc.
$882
ABBVIE INC.
$853
Teva Pharmaceuticals USA, Inc.
$652
Amgen Inc.
$556
Lundbeck LLC
$403
Celgene Corporation
$395
ACADIA Pharmaceuticals Inc
$325
Takeda Pharmaceuticals U.S.A., Inc.
$318
Genentech USA, Inc.
$236
Grifols USA, LLC
$235
Lilly USA, LLC
$228
PFIZER INC.
$218
US WorldMeds, LLC
$192
GENZYME CORPORATION
$186
SK Life Science, Inc.
$169
Janssen Pharmaceuticals, Inc
$158
Avanir Pharmaceuticals, Inc.
$148
Eisai Inc.
$134
Neurocrine Biosciences, Inc.
$127
Mallinckrodt Hospital Products Inc.
$97
TG Therapeutics, Inc.
$96
Acorda Therapeutics, Inc
$86
Otsuka America Pharmaceutical, Inc.
$68
Corium, LLC
$65
Biohaven Pharmaceutical Holding Company Ltd.
$64
BANNER LIFE SCIENCES, LLC
$62
Supernus Pharmaceuticals, Inc.
$61
UCB, Inc.
$50
Mallinckrodt LLC
$49
IMPEL PHARMACEUTICALS INC.
$44
Akcea Therapeutics, Inc.
$42
Amylyx Pharmaceuticals, Inc.
$41
Neuronetics, Inc.
$40
CATALYST PHARMACEUTICALS, INC.
$39
Vertical Pharmaceuticals, LLC
$35
ARGENX US, INC.
$33
Allergan Inc.
$31
Medtronic, Inc.
$29
Bayer HealthCare Pharmaceuticals Inc.
$29
Sunovion Pharmaceuticals Inc.
$28
CSL Behring
$28
LivaNova USA, Inc.
$27
GE HEALTHCARE
$25
ASSERTIO THERAPEUTICS, Inc.
$24
TG THERAPEUTICS, INC.
$23
Exeltis, USA Inc.
$23
Impax Laboratories, Inc.
$21
Upsher-Smith Laboratories LLC
$21
MITSUBISHI TANABE PHARMA AMERICA, INC.
$20
Catalyst Pharmaceuticals, Inc.
$19
MDD US Operations, LLC
$18
UPSHER-SMITH LABORATORIES LLC
$17
Mylan Specialty L.P.
$16
Vanda Pharmaceuticals Inc.
$16
E.R. Squibb & Sons, L.L.C.
$15
Strongbridge US INC.
$15
Ipsen Biopharmaceuticals, Inc
$15
Mallinckrodt Enterprises LLC
$14
AstraZeneca Pharmaceuticals LP
$13
Promius Pharma LLC
$13
Octapharma USA, Inc.
$12
Top 3 companies account for 90.4% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · Adlarity · Aimovig · Austedo XR · BAFIERTAM · BOTOX · BOTOX THERAPEUTIC · BRILINTA · BRIUMVI · Betaseron · COPAXONE · DUOPA · Dysport · EMGALITY · FIRDAPSE · GAMMAGARD · GILENYA · Gamunex-C · Glatiramer Acetate · Gocovri · Gralise · HYQVIA · Hizentra · INBRIJA · INGREZZA · KESIMPTA · KEVEYIS · KISUNLA · LEMTRADA · LEQEMBI · Leqembi · MAVENCLAD · MAYZENT · MYOBLOC · Mavenclad · NAMZARIC · NEUROSTAR TMS THERAPY SYSTEM · NORTHERA · NUEDEXTA · NUPLAZID · NURTEC ODT · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OSMOLEX ER · OXTELLAR XR · Ocrevus · Ocrevus Zunovo · Ongentys · PANZYGA · PERCEPT PC BRAINSENSE · PLEGRIDY · POMPE - DISEASE · PONVORY · PURIFIED CORTROPHIN GEL · Ponvory · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · RADICAVA · RELEXXII · RELYVRIO · REXULTI · RYTARY · Rebif · Rystiggo · SOLIRIS · Soliris · TECFIDERA · TEGSEDI · TOSYMRA · TROKENDI XR · TYSABRI · Trudhesa · Tysabri · UBRELVY · ULTOMIRIS · UPLIZNA · VNS Therapy · VUMERITY · VYEPTI · VYVGART · Vimpat · Xadago · ZEPOSIA · Zembrace
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (90%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 7% for neurology in NY.

Looking for a neurology specialist in New York?
Compare neurologists in the New York area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
1,282
Per 100K population
78.8
County median income
$104,553
Nearest hospital
MOUNT SINAI HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Deangelis is a clinical cardiology specialist, with above-average Medicare volume (top 23% in NY), with speaking/promotional industry engagement in the top 7% of NY peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Deangelis experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Deangelis performed 668 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Deangelis receive payments from pharmaceutical companies?
Yes. Dr. Deangelis received a total of $107,968 from 66 companies across 900 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Deangelis's costs compare to other neurologists in New York?
Dr. Deangelis's average Medicare payment per service is $97. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Deangelis) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →